People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Other, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gallant Pet, Inc. | — | Other | Series B | $42.6M | $49.3M | 2025 |
| Strategic Pharmaceutical Solutions, Inc | — | Pharma | Series A | $23.3M | $46.2M | 2015 |
Doug Drew at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Doug Drew on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott Anderson | 1 | 12 |
| Teymour Boutros-Ghali | 1 | 5 |
| Misti Ushio | 1 | 4 |
| Steve Fisher | 1 | 3 |
| Davis Brimer | 1 | 3 |
| Doug Jones | 1 | 3 |
| Aaron Hirschhorn | 1 | 2 |
| Bob Antin | 1 | 2 |
| Aaron Schacht | 1 | 2 |
| Richard Jennings | 1 | 2 |
| James Ratigan | 1 | 2 |
| George Henriques | 1 | 1 |
| David Laurance | 1 | 1 |
| Linda Black | 1 | 1 |
| Greg Colvin | 1 | 1 |
| Darryl Rawlings | 1 | 1 |
| Jim Cleary | 1 | 1 |
| Kurt Green | 1 | 1 |
| Thomas Friar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.